To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naive patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
Deadline
The time limit for receipt of tenders was 2018-04-27.
The procurement was published on 2018-04-20.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Object Scope of the procurement
Title: Supply of Infliximab or Biosimilar
Products/services: Pharmaceutical products📦
Short description:
“To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab Biosimilar to patients in Our Lady’s Children’s...”
Short description
To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab Biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
Show more
Total value of the procurement (excluding VAT): EUR 550 000 💰
1️⃣
Additional products/services: Pharmaceutical products📦
Place of performance: Éire/Ireland🏙️
Main site or place of performance: Our Lady's Children's Hospital, Crumlin
Description of the procurement:
“To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab Biosimilar to patients in Our Lady’s Children’s...”
Description of the procurement
To appoint a single provider for the provision, supply, support and delivery of Infliximab or Infliximab Biosimilar to patients in Our Lady’s Children’s Hospital Crumlin (OLCHC). It is envisaged that Infliximab-naïve patients in OLCHC will receive the tendered product initially with a view to switch all existing patients within 6 months.
Show more Award criteria
Quality criterion (name): Quality of Supply
Quality criterion (weighting): 20 %
Quality criterion (name): Quality and Fitness for Purpose
Quality criterion (name): Value Add
Quality criterion (weighting): 15 %
Cost criterion (name): Overall Cost
Cost criterion (weighting): 45 %
Procedure Type of procedure
Open procedure
Administrative information
Previous publication concerning this procedure: 2018/S 079-176043
Award of contract
1️⃣
Contract Number: RFT 131644
Title: RFT 131644 — Supply of Infliximab or Biosimilar
Date of conclusion of the contract: 2018-08-17 📅
Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from other EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 0
Name and address of the contractor
Name: Pfizer Healthcare Ireland
Postal address: 9 Riverwalk, National Digital Park
Postal town: Dublin
Postal code: 22
Country: Ireland 🇮🇪
Phone: +44 353526186000📞
E-mail: caroline.reidy@pfizer.com📧
Fax: +44 353526136311 📠
Region: Dublin🏙️
The contractor is an SME
Information on value of the contract/lot (excluding VAT)
Currency code: EUR 💰
Lowest offer: 512448.00
Highest offer: 559000.00
Complementary information Review body
Name: High Court
Postal address: Inns Quay
Postal town: Dublin
Postal code: 7
Country: Ireland 🇮🇪
Source: OJS 2018/S 186-420045 (2018-09-26)